Synaptogenix, Inc. (SNPX)
NASDAQ: SNPX · Real-Time Price · USD
2.350
+0.051 (2.22%)
Apr 25, 2025, 4:00 PM EDT - Market closed
Synaptogenix Market Cap
Synaptogenix has a market cap or net worth of $3.39 million as of April 29, 2025. Its market cap has decreased by -36.75% in one year.
Market Cap
3.39M
Enterprise Value
-14.27M
1-Year Change
-36.75%
Ranking
Category
Stock Price
$2.35
Market Cap Chart
Since December 15, 2020, Synaptogenix's market cap has decreased from $5.28M to $3.39M, a decrease of -35.80%. That is a compound annual growth rate of -9.64%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 28, 2025 | 3.39M | -27.91% |
| Dec 31, 2024 | 4.70M | -15.16% |
| Dec 29, 2023 | 5.54M | -34.23% |
| Dec 30, 2022 | 8.43M | -85.16% |
| Dec 31, 2021 | 56.80M | 652.77% |
| Dec 31, 2020 | 7.55M | 42.86% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 794.31B |
| UnitedHealth Group | 381.06B |
| Johnson & Johnson | 371.93B |
| AbbVie | 329.14B |
| Novo Nordisk | 272.76B |
| Abbott Laboratories | 223.47B |
| AstraZeneca | 214.65B |
| Novartis AG | 211.71B |